Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 21.91% vs -9.08% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -672.73% vs -79.44% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 41.67% vs -45.45% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs -25.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Knight Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 21.91% vs -9.08% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.34% vs 6.34% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -672.73% vs -79.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -563.16% vs -205.56% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 41.67% vs -45.45% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -51.98% vs 47.50% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs -25.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.35% vs -23.33% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






